KT

Karthikeyan Thamasundaram

Active Director Director DIN 11174638
DIN 11174638 First appointment Jun 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Karthikeyan Thamasundaram

Data last updated:

Karthikeyan Thamasundaram is a Director at A4 Bhanu Hospital Private Limited (since 2025). The company operates in Healthcare.

DIN 11174638
Primary Designation Director
Industry Healthcare
First Appointment 30 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
A4 Bhanu Hospital Private Limited U86100TN2025PTC181882
Director30 Jun 20252025Active

Board colleagues of Karthikeyan Thamasundaram

NameDINCompanyDesignation
Ashok Kumar10497606A4 Bhanu Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
A4 Bhanu Hospital Private Limited
Premium access

Shareholding and investment profile for Karthikeyan Thamasundaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karthikeyan Thamasundaram

Karthikeyan Thamasundaram currently holds 1 directorship: A4 Bhanu Hospital Private Limited (Director, since 30 Jun 2025).

Karthikeyan Thamasundaram was first appointed on 30 Jun 2025 as Director at A4 Bhanu Hospital Private Limited.

The current boards of Karthikeyan Thamasundaram's companies include Ashok Kumar (A4 Bhanu Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available